Immunic Inc (IMUX) Transcripts
Q3 2024 Immunic Inc Earnings Call Transcript
Nov 07, 2024
$1.18
Earnings
Q2 2024 Immunic Inc Earnings Call Transcript
Aug 08, 2024
$1.34
(+14.53%)
Earnings
Q3 2023 Immunic Inc Earnings Call Transcript
Nov 14, 2023
$0.9902
(+2.16%)
Earnings
Immunic Inc To Discuss Interim Data Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive MS Call Transcript
Oct 10, 2023
Q2 2023 Immunic Inc Earnings Call Transcript
Aug 03, 2023
$2.13
(-1.39%)
Earnings
Immunic Inc To Host Key Opinion Leaders Transcript
Jul 20, 2023
Q1 2023 Immunic Inc Earnings Call Transcript
May 11, 2023
$1.82
(+1.68%)
Earnings
Immunic Inc To Discuss IMU-856 Clinical Phase 1b Results in Celiac Disease Call Transcript
May 04, 2023
Immunic Inc To Discuss Phase 2b CALDOSE-1 Maintenance Phase Data Call Transcript
Apr 05, 2023
Q4 2022 Immunic Inc Earnings Call Transcript
Feb 23, 2023
$1.97
(+4.23%)
Earnings
Immunic Inc Celiac Disease R&D Webcast Transcript
Feb 09, 2023
Immunic Inc Corporate Call Transcript
Nov 17, 2022
Q3 2022 Immunic Inc Earnings Call Transcript
Nov 03, 2022
$1.58
(-7.60%)
Earnings
Immunic Inc Webinar: IMU-856 Phase 1 SAD/MAD Data in Healthy Human Subjects Transcript
Sep 20, 2022
Q2 2022 Immunic Inc Earnings Call Transcript
Aug 04, 2022
$4.79
(+23.14%)
Earnings
Immunic Inc Corporate Update Transcript
Jun 02, 2022
Q1 2022 Immunic Inc Earnings Call Transcript
May 10, 2022
$5.5
(+5.36%)
Earnings
Q4 2021 Immunic Inc Earnings Call Transcript
Feb 24, 2022
$10.72
(-9.15%)
Earnings
Q3 2021 Immunic Inc Earnings Call Transcript
Nov 04, 2021
$10.25
(+2.60%)
Earnings
Immunic Inc Discuss Overall MS Development Strategy - Corporate Call Transcript
Jul 01, 2021
Q2 2020 Immunic Inc Earnings Call Transcript
Aug 03, 2020
Earnings